IP Library Granted Patent US 11,396,526
Granted Patent B2
US 11,396,526 · App. 17/564,471 · Granted Jul 26, 2022

Process technology for biological product manufacturing and downstream purification

Inventors: Jason M. Criscione (Chelmsford, MA); Ali Ersen (Chestnut Hill, MA); John R. Linton (Concord, MA); Sammy S. Datwani (Pleasanton, CA)
Assignee: Mobius Biomedical, Inc.
C07K1/36B01D15/1892B01D15/203B01D15/3809B01D57/02B01D59/10B01D63/10B01D69/02B01D69/10B01D69/14B01D71/68C07K1/22C07K1/26C07K1/34C07K16/00B01D2313/24B01D2325/02C07K2319/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,396,526
App. No.
17/564,471
Granted
Jul 26, 2022
Kind
B2
Abstract

Provided herein are, inter alia, biological manufacturing and downstream purification processes.

Claims (13)

1. A free-flow electrophoresis apparatus for separating a mixture into two or more fractions, at least one fraction containing a biological product, comprising:

at least one inlet and at least one outlet configured to permit continuous fluid flow between the at least one inlet and the at least one outlet;

at least one fluidic channel created between two parallel plates and configured to create an electric field gradient orthogonal to the direction of fluid flow;

electrode channels comprising an anodic electrode channel and a cathodic electrode channel, wherein the electrode channels are configured to be connected to the main separation channel by liquid contact through a wall gap positioned between the electrode channels and the main separation channel;

at least one electrode channel de-bubbler comprising at least one gas permeable and hydrophobic membrane or porous material configured to remove electrolysis bubbles near the point of generation by a vacuum system to create a bubble-free main separation channel;

at least one liquid circuit breaker configured to disconnect a liquid connected to voltage prior to interacting with at least one sensor or detector;

an active cooling system; and

at least one collection vessel.

2. The apparatus of claim 1 , wherein a top portion of the electrode channels are sealed with at least one gas permeable and hydrophobic membrane in communication with a vacuum system to remove bubbles, and wherein the electrode channels are open at the bottom of the channels and configured to enable liquid contact of electrode solution with the main separation channel solution through a wall gap.

3. The apparatus of claim 1 , wherein wall gap is about 0.01 mm to about 0.25 mm.

4. The apparatus of claim 1 , wherein the liquid circuit breaker comprises a pressurized vessel configured to maintain flow rate and creates droplets that break the circuit from the solution connected to voltage.

5. The apparatus of claim 1 , wherein the at least one sensor is an in-line sensor.

6. The apparatus of claim 1 , further comprising at least two free-flow electrophoresis apparatuses connected in series and operated in an isoelectric focusing mode, a zone electrophoresis mode, an isotachophoresis mode, or combinations thereof, to enable a staged purification.

Assignments (2)
CHANGE OF NAME Recorded Feb 28, 2023
From: MOBIUS BIOMEDICAL INC.
To: ENQUYST TECHNOLOGIES INC.
Reel/Frame 062885/0061 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 13, 2022
From: CRISCIONE, JASON M.; ERSEN, ALI; LINTON, JOHN R.; DATWANI, SAMMY S.
To: MOBIUS BIOMEDICAL, INC.
Reel/Frame 058639/0719 →
Continuity (5)
Division 17474232 · Sep 14, 2021
Provisional Application 63154108 · Feb 26, 2021
Provisional Application 63154109 · Feb 26, 2021
Provisional Application 63077766 · Sep 14, 2020
Related Publication 20220177519A1 · Jun 9, 2022